RAMANDEEP KAUR: Open Payments
NPI 1598283228 · NIAGARA FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$158 in 8 payments from 6 companies in 2025. Trend: 2023 $69 · 2024 $711 · 2025 $158
Food & beverage: $158
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $55 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Novo Nordisk Inc | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: REPATHA, DATROWAY, Ozempic, SPRAVATO, UZEDY, FARXIGA.
Industry payments across NY — which companies pay providers there.
